2018 Annual Sessions

OS04 - ORAL SESSION 04 - Immunosuppression in Heart Transplantation: Lessons Learned

Apr 11, 2018 8:30am ‐ Apr 11, 2018 10:00am


Description

(19) Multicenter Study to Determine Up to 5 Year Clinical Outcome of Heart Transplant Recipient Receiving Rituximab Versus Placebo Outcomes in Subjects Previously Randomized in the CTOT-11 Study
Randall Starling, MD, MPH

(20) Scandinavian Heart Transplant Everolimus De Novo Study With Early Calcineurin Inhibitors Avoidance (Schedule): Results After 6 Years of Follow-up
Arne Andreassen, MD, PhD

(21) TICTAC 10: Ten Year Follow-up of the Tacrolimus in Combination Tacrolimus Alone Compared Trial
David Baran, MD

(22) Clinical Outcomes Associated With mTORi Initiation in Adult Heart Transplant: An ISHLT Registry Analysis
Juan Duero Posada, MD

(23) Quantiferon Monitor Assay Identifies Over-Immunosuppressed Patients with Adverse Outcomes After Heart Transplantation: Towards the Definition of a Phenotype of Immune Frailty
Luciano Potena, MD, PhD

(24) 5-Year Outcome of Renal Function with Patients on Renal-Sparing Protocol After Heart Transplantation
Jignesh Patel, MD, PhD

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
* - Indicates answer is required.
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content